ABSTRACT. We used chronic fetal glucose infusion to test the hypothesis that chronic fetal hyperglycemia and hyperinsulinemia inhibit the development of @-receptor binding capapcity (Bmax) in fetal lamb lung. Glucose was infused (14 f 4 mg/kg/h, mean f SD) into eight twin and four singleton fetuses from 112 days gestation until death between 118-145 days gestation. The other eight twins and eleven additional singleton fetuses served as controls. Serum glucose levels were elevated 2-fold and serum insulin levels were elevated 3-fold in the glucose-infused fetuses. In the control fetuses @-receptor Bmax increased 2.5-folld between 130 days gestation and term. However, this increase was attenuated to 1.5-fold in the glucose infused fetuses, p < 0.01. The 50% inhibition of Bmax was similar in both male and female fetuses, except that the Bmax fell to 30% lower levels in males, p < 0.01. Chronic glucose infusion also resulted in an 80% reduction in lung lavage saturated phosphatidylcholine content, and an 85% reduction in tracheal fluid saturated phosphatidylcholine contemt,p < 0.001. Lung lavage and tracheal fluid saturated phosphatidylcholine content correlated significantly with beta receptor Bmax (r = 0.9, r = 0.85). We conclude that chronic glucose infusion inhibits the development of 8-receptor binding in fetal lamb lung, and that this effect is greater in males than females. Such a mechanism could be a factor in the predisposition of infants of diabetic mothers to develop respiratory distress and could contribute to a male disadvantage in respiratory morbidity. (Pediatr Res 24: 171-174,1988) Abbreviations Bmax, maximal binding capacity IDM, infant of diabetic mother RDS, respiratory distress syndrome SPC, saturated phosphatidylcholine DHA, dihydroalprenolol
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We have shown that fetal hyperinsulinemia occuring with either hyperglycemia (3) or hypoglycemia (4) is capable of inhibiting surface active material flux into the tracheal fluid of chronically catheterized fetal lambs. In human diabetic pregnancy, chronic fetal hyperglycemia with secondary hyperinsulinimia is more likely to occur. Surface active material flux into the tracheal fluid of fetal lambs has been used by several groups as a marker of in utero surfactant production (3-6). Recently we have found t h a t c h r o n i c fetal hyperglycemia a n d hyperinsulinemia also reduces the SPC content of lung lavage, and impairs lung stability to air inflation and deflation in fetal lambs (7), data that are compatible with decreased availability of surfactant in the fetal airways.
Beta-receptor binding capacity has been shown to increase during the latter part of gestation in several species and this increase can be modulated by several hormones (8) . We have recently shown that surface active material flux into the tracheal fluid of fetal lambs is significantly correlated with the increase in pulmonary P-receptor binding capacity (9) , and that the fetal lamb lung responds to P-agonist stimulation with increased SPC in lung lavage and improved lung stability (10) .
Our study was designed to test the hypothesis that chronic hyperglycemia and hyperinsulinemia induced by chronic glucose infusion inhibit the development of preceptor binding capacity in fetal lamb lung.
METHODS
Animal preparation. Gestational age of pregnant sheep was determined from the time of mating (Nebeker Farms, Santa Monica, CA). In addition, fetal age was estimated from ossifica-. . tion centers in utero (1 1) and b; extrapolation of fetal weight and crown-rump measurements at delivery (12) : dating by these methods agreed with 3 days.
Ewes were operated on at 110 days gestation under epidural anesthesia with 0.5% Pontocaine as described previously (3, 5) .
Catheters were laced in a fetal carotid arterv. iuaular vein. and * , " -the trachea. he tracheal catheter was connected at 600-ml latex bag that was left in the amniotic sac. A separate catheter leading from the bag and the other catheters was exteriorized through Maternal diabetes mellitus has been associated with a curnu-the ewe's flank. After the operation the ewes received 1.2 million lative 23-fold increase in the incidence of neonatal RDS (1). U procaine penicillin and 1 g kanamycin intramuscularly for 5 Stubbs and Stubbs (2) have suggested that fetal hyperinsulinemia days. 'The fetuses received 200,000 U penicillin and 10 mg may be the common link between maternal hyperglycemia and kanamycin intravenously every day. RDS. However, the exact etiology of RDS among IDM remains Glucose infusion. ml; approximately 1 % of fetal blood volume) were obtained every 48 to 72 h including the day of death. Arterial blood gases were measured at 39" C using a Corning 178 blood gas analyzer (Corning Medical and Scientific, Medfield, MA). Serum was separated from the arterial blood and stored at -40" C for subsequent analysis. Serum glucose concentration in mg/dl was measured by the glucose oxidase method using a YSI-23A glucose analyzer (Yellow Springs Instruments, Yellow Springs, OH). Serum insulin concentration in pU/ml was measured using a double antibody radioimmunoassay. Tracheal fluid was collected dailv. . ..--The fetuses were rapidly removed from the uterus immediately after euthanasia of the ewe and fetuses with sodium pentobarbital. The tracheal cannula was clamped and the lungs and trachea were then rapidly removed from the fetal thorax and weighed. Small pieces of the right lung were immediately frozen in liquid nitrogen and the pieces were stored at -70" C for subsequent analysis. The assays reported below using lung tissue preserved by this technique were stable and reproducible over a period of several months.
The left main stem bronchus was cannulated and pressurevolume curves were recorded. Lung lavage was performed, and SPC was extracted from the lavage fluid and from the tracheal fluid exactly as described by Warburton et al. (7) .
Beta-adrenergic receptor binding assay. Beta-receptor binding assavs were adavted from the methods described bv Cabelli and ~a k o n (13) add Maniscalco and Shapiro (14) asmodified by Hung et al. (15) , and were performed exactly as described by Warburton et al. (9) for fetal lamb lung. Control tubes containing no tissue were included in all experiments; nonspecific binding ligand to filters was always less then 0.3% of the total counts filtered. Specific binding of DHA to lung membrane preparations was analyzed in the presence of 10 pM propranolol using six concentrations of DHA ranging from 0.5 to 20 mM to span the K by the method of Scatchard (16) . Nonspecific binding was 18 k 2% of the total binding. Protein determinations for all assays was the method of Markwell et al. (17) using bovine serum albumin as standard.
The following comparisons between the control and glucoseinfused fetuses were made using analysis of variance with Newman-Keuls test: control versus glucose-treated fetuses (1 18-148 days and 1 30-148 days gestation); males versus females for both control and glucose-treated fetuses (130-148 days gestation).
Results are given as mean + SD. Statistical significance was accepted with a p < 0.05.
RESULTS
Chronic glucose infusion at a rate of 14 k 4 mg/kg/min (mean * SD) resulted in a 2-fold elevation in serum glucose level from 23 + 3 mg/dl in the control fetuses to 48 + 5 mg/dl in the glucose infused fetuses, p < 0.00 1. Serum insulin levels were also elevated 3-fold from 15 + 4 pU/ml in the control fetuses to 45 + 5 pU/ml in the glucose infused fetuses. p < 0.00 1. A comparison of pulmonary /I-receptor Bmax between male and female fetuses after 130 days gestation is shown in Table 1 . Glucose infusion resulted in a 50% reduction in pulmonary Bmax in both male and female fetuses after 130 days gestation. However, the Bmax fell to 30% lower levels in males after glucose infusion. The K of pulmonary 0-receptors in all the fetuses was 1.3 + 0.4 nM and was not significantly affected by glucose infusion or fetal gender.
We have shown previously that P-receptor Bmax correlates with surface active material flux into the tracheal fluid of fetal lambs (9) . A correlation between fetal pulmonary preceptor Bmax and lung lavage SPC content in both control and glucoseinfused fetal lambs is shown in Figure 2 . A similar correlation was found between Bmax and tracheal fluid SPC content (r = 0.85, p < 0.005, data not shown).
DISCUSSION
Intravenous glucose infusion to chronically catheterized fetal lambs resulted in chronic hyperglycemia and hyperinsulinemia similar to that which we have reported previously (3). Fetal arterial blood gases and tracheal fluid production rate were not significantly altered by the rate of glucose infusion reported herein. The increase in 0-receptor binding capacity during the last third of gestation in both the catheterized and uncatheterized control fetuses was similar to the data we have reported previously in fetal lambs (9) .
Beta-receptor-mediated mechanisms have been implicated in the control of surfactant release, as well as in the reabsorption of alveolar liquid (10, 18) . Inhibition of /I-receptor binding might therefore inhibit surfactant availability in the airways and inhibit resorption of liquid from the alveoli, effects that are compatible with the known pathophysiology of RDS. In our study, inhibition of P-receptor binding between 130 days gestation and term was found to correlate with reduced lung lavage and tracheal fluid surfactant phospholipid content.
The development of preceptor binding capacity in the fetal lung is controlled by several hormones (8) . Glucocorticoids have been reported to increase the @-receptor binding capacity of fetal rabbit lung (19) , whereas hypothyroidism was shown to inhibit preceptor binding capacity in fetal rat lung (20) . In addition, Maniscalco et al. (14) and Warburton et al. (21) have reported synergistic effects of glucocorticoid and thyroid hormones on Preceptor binding capacity in fetal rabbit lung explants in culture and in fetal lamb lung, respectively.
We have recently reported that pulmonary preceptor binding capacity increases more rapidly in female fetal lambs than males (9) . We found that between 128-138 days gestation, pulmonary Bmax was 1.4-fold greater in females than males, but that there was no significant difference closer to term (9) . In our study, the difference between male and female controls was not statistically significant because it included term fetuses. However, glucose infusion apeared to produce a significant male disadvantage in P-receptor binding capacity. Padbury et al. (22) have also reported that female rabbit fetuses develop P-receptor binding capacity earlier in gestation than do males. Male gender and dihydrotestosterone have also been reported to inhibit the development of fetal surfactant phospholipids (23, 24) . Moreover, according to Robert et al. (I) , male offspring of human diabetic mothers have a higher relative risk of developing RDS. Fatal RDS has also been noted more commonly among male IDM (25, 26).
It is not clear from our study if the inhibitory effects of glucose infusion on P-receptor binding are mediated by hormonal interactions at the transcriptional level or are due to local membrane effects on the surface of lung cells. We have shown that chronic glucose infusion inhibits the maturational response of the fetal lamb lung to cortisol (27). However, Neufield et al. (28) have reported increased binding capacity of insulin receptors in pulmonary membranes from the pups of alloxan diabetic rabbits and have also reported similar results in cord blood monocytes from human ;[DM (29), findings that were attributed to decreased membrane fluidity with increased exposure of insulin receptors at the cell surface. Brown and Longmore (30) have also recently reported quite rapid changes in the rate of surfactant secretion in response to P-agonist in type I1 pneumocytes freshly isolated in vitro from the lungs of Streptozotocin diabetic rats. The latter effects could be reversed by in vivo insulin treatment before death, but not by insulin treatment of the cells in vitro.
We conclude that chronic hyperglycemia and hyperinsulinemia, resulting from chronic glucose infusion, inhibits the development of P-receptor binding capacity in fetal lamb lung, and that the inhibition is greatest in glucose-infused male fetuses. We speculate that decreased binding capacity of pulmonary P-receptors may inhibit the effects of P-agonist on the fetal lung (31). Such a mechanism could be a factor in the predisposition of IDM with poor maternal glucose homeostasis to develop RDS, and could contribute to a male disadvantage in respiratory morbidity.
